Compare AST SpaceMobile Inc (ASTS) vs Boston Scientific Corporation (BSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AST SpaceMobile Inc vs Boston Scientific Corporation — how do they compare? AST SpaceMobile Inc trades at $67.76 (market cap $21.90B), while Boston Scientific Corporation trades at $44.74 (market cap $66.54B). The key difference: Boston Scientific Corporation is far larger — about 3× AST SpaceMobile Inc's market cap, and AST SpaceMobile Inc is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| ASTS | BSX | |
|---|---|---|
Market Cap | $21.90B | $66.54B |
Sector | Media | Health |
52-Week High | $133.09 | $108.14 |
52-Week Low | $36.91 | $42.68 |
Enterprise Value | $21.87B | $76.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AST SpaceMobile (ASTS) trades at $67.58, down 7.83% amid a bearish technical signal and negative earnings trends. The company reported a net loss of $341.94M on $70.92M revenue in 2025, with a P/S ratio of 235.37 indicating high valuation relative to sales. Recent news highlights volatility driven by satellite launch developments and competition in the space connectivity sector.
Outlook hinges on execution of satellite deployments and partnerships with AT&T and Verizon, offering growth potential but facing significant execution and funding risks. High cash burn and negative margins underscore the speculative nature, with analyst consensus target at $90.33 suggesting cautious optimism if operational milestones are met.
BSX trades at $44.65, down 0.27% on the day, with a bearish technical signal from moving averages despite recent earnings beats. Revenue grew to $20.07B in 2025 with a net income margin of 17.29%, while valuation metrics show a P/E of 18.73 and P/S of 3.25. The stock faces headwinds from competitive pressures and guidance cuts, but maintains strong analyst support with an 88% buy rating.
The outlook hinges on execution amid slowing growth in key segments; upside exists if the company meets revised guidance, but risks include market volatility and sustained competitive threats. The consensus price target of $71.20 suggests significant potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AST SpaceMobile Inc
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building the global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on extensive IP and patent portfolio. AST is on a mission to eliminate the connectivity gaps faced by mobile subscribers and finally bring broadband to the billions who remain unconnected.
Read more on ASTS →About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →
